Neutralization of D-tyrosine methyl ester hydrochloride (C₁₀H₁₄ClNO₃, 231.68 g/mol) with 1.05–1.10 equivalents of N-methylmorpholine in anhydrous N,N-dimethylformamide at 0–5 °C releases the free amino ester for solution-phase peptide bond formation. The salt is pre-dried in a vacuum oven at 40 °C until water content by Karl Fischer titration per USP <921> Method Ia is below 0.1% w/w; residual water above this threshold reduces conversion when carbodiimide reagents are used because O-acylisourea intermediates are hydrolytically quenched. The free amine is activated with 1.0–1.1 equivalents of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) in the presence of 2.0 equivalents of N,N-diisopropylethylamine, and the resulting solution is added to an N-protected amino acid or peptide fragment dissolved in anhydrous dimethylformamide. Coupling progress is monitored by reverse-phase HPLC using a 150 mm × 4.6 mm C₁₈ column with a 0.1% trifluoroacetic acid water/acetonitrile gradient, UV detection at 220 nm and 254 nm, and mass confirmation by single-quadrupole LC-MS. The process yields D-tyrosine-containing peptide methyl esters that serve as intermediates for D-amino-acid-containing peptide APIs and research-grade peptide fragments; the final amide or acid form is determined by subsequent C-terminal deprotection.

Workup after complete consumption of the D-tyrosine methyl ester starting material involves dilution with ethyl acetate, sequential washing with 0.5 M potassium hydrogen sulfate, 5% sodium bicarbonate, and brine, drying over anhydrous sodium sulfate, and concentration under reduced pressure at a bath temperature not exceeding 35 °C. The methyl ester retains sufficient orthogonal protection to allow selective N-terminal deprotection without affecting the carboxy ester; however, the phenolic hydroxyl of the tyrosine side chain remains unprotected and can react with activated carbonyl species if the pH exceeds 8.5 or if excess coupling reagent remains after aqueous quench. Residual solvent content of the isolated peptide methyl ester is measured by headspace gas chromatography per USP <467>, and residual water is confirmed by USP <921> before storage at 2–8 °C under argon.

When Does Methyl Ester Hydrolysis Compete with Amide Bond Formation?

The methyl ester function remains intact through carbodiimide-mediated coupling but is cleaved selectively after peptide assembly when a free C-terminal carboxylate is required for solid-phase conjugation or cyclization. Hydrolysis is performed in a 50 L jacketed glass reactor using 1.05 equivalents of lithium hydroxide monohydrate in tetrahydrofuran/water 3:1 v/v at 0–5 °C. The base is added through a peristaltic pump at a fixed rate so that the pH, measured with an in situ glass electrode, does not exceed 11.5. When the pH drifts above 11.5, or when the internal temperature exceeds 10 °C, proton abstraction at the α-carbon competes with the desired ester cleavage, leading to racemization of the D-configured residue. Because the phenolic side chain of tyrosine is also susceptible to oxidation under alkaline conditions, the reactor headspace is blanketed with nitrogen and a 0.1% w/v sodium thiosulfate solution is prepared as a quench adjunct. Reaction completion is determined by reverse-phase HPLC area normalization; the methyl ester intermediate peak is considered consumed when it accounts for less than 1.0% of the total area at 220 nm.

The hydrolysate is acidified to pH 3.5–4.0 with 0.5 M citric acid and extracted twice with ethyl acetate. The combined organic phase is washed with brine, dried over magnesium sulfate, and concentrated at 25–30 °C under reduced pressure. The resulting D-tyrosine-containing peptide acid is analyzed for enantiomeric purity by chiral HPLC after acid hydrolysis and Marfey-type derivatization. The accepted release criterion is resolution R_s ≥ 1.5 between the D- and L-tyrosine derivatives on a 250 mm × 4.6 mm C₁₈ column with a chiral ligand-exchange mobile phase prepared from aqueous copper(II) acetate and N,N-dimethyl-L-phenylalanine. Published kinetic data for this specific D-enantiomer configuration are limited; therefore, the hydrolysis control space is typically established by design-of-experiments during process qualification rather than by extrapolating data from L-tyrosine methyl ester hydrochloride.

Fmoc protection of D-tyrosine methyl ester hydrochloride is carried out in aqueous dioxane with sodium carbonate, using 1.2 equivalents of Fmoc succinimidyl carbonate dissolved in 1,4-dioxane. The hydrochloride salt is first neutralized in situ with 10% w/v aqueous sodium carbonate at 0–5 °C; the free amine is then treated with a dioxane solution of the Fmoc reagent over 30 min. The reaction mixture is allowed to warm to 20–25 °C and stirred under nitrogen until the ninhydrin test on silica gel TLC is negative. Because the phenolic hydroxyl of tyrosine remains unprotected, the pH is maintained between 8.0 and 8.5; at higher pH, O-acylation of the phenoxide competes with N-acylation and reduces the yield of Fmoc-D-tyrosine methyl ester. The product is extracted with ethyl acetate after dilution with water, washed with diluted hydrochloric acid and brine, dried over sodium sulfate, and concentrated to a viscous oil at 30 °C. The resulting N-Fmoc methyl ester is a protected C-terminal fragment for solution-phase peptide elongation; if solid-phase peptide synthesis is required, the methyl ester is saponified to Fmoc-D-tyrosine-OH using lithium hydroxide in THF/water under the same pH constraints described for peptide saponification.

The isolated Fmoc-D-tyrosine methyl ester is characterized by 1H and 13C nuclear magnetic resonance spectrometry, mass spectrometry, and optical rotation per USP <781>. Diastereomeric purity is verified by chiral HPLC using an amylose tris(3,5-dimethylphenylcarbamate) stationary phase, typically a 250 mm × 4.6 mm Chiralpak IA column, eluted with hexane/2-propanol mixtures containing 0.1% trifluoroacetic acid. The D-enantiomer is eluted as a single peak, and the unwanted L-enantiomer, if present, is resolved with R_s ≥ 1.5. The protected intermediate can be stored for short periods at 2–8 °C; long-term storage is at −20 °C under argon in glass containers because the methyl ester is hygroscopic and the Fmoc group is base-labile.

Chiral HPLC Verification of the D-Enantiomer in Peptide Intermediates

Chiral purity of the free amine generated from D-tyrosine methyl ester hydrochloride is determined after pre-column derivatization with 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide or by direct phase separation on a crown ether-based chiral column. The direct method uses a 150 mm × 4.0 mm Crownpak CR(+) column with an acidic perchlorate buffer and methanol mobile phase, UV detection at 254 nm, and a flow rate of 0.5 mL/min. Sample solutions are prepared at 0.1 mg/mL in mobile phase and filtered through a 0.22 µm polyvinylidene difluoride membrane. Under these conditions the D-enantiomer elutes before the L-enantiomer; the assay is validated for specificity, linearity, accuracy, repeatability, intermediate precision, and limit of quantitation according to ICH Q2(R1).

The acceptance criteria in the table are used for release of D-tyrosine methyl ester hydrochloride as a chiral building block in peptide intermediate manufacturing. In addition, identification is confirmed by infrared spectroscopy against a reference lot, and water content is measured by Karl Fischer titration per USP <921> Method Ia. Residue on ignition is determined according to USP <281> to ensure the material does not introduce inorganic contamination into chiral peptide synthesis reactors. Working standards are stored at −20 °C in amber glass vials under argon and are equilibrated to ambient temperature inside a desiccator before opening to prevent condensation-derived hydrolysis.

Enzymatic resolution studies use D-tyrosine methyl ester hydrochloride as a substrate in enantioselective hydrolysis screening for lipases, esterases, and proteases. A typical screening format employs 0.2 M substrate in phosphate buffer at 25 °C and pH 7.0, with immobilized enzyme loadings between 5 mg and 50 mg per millimole of ester. The hydrochloride salt provides a water-soluble D-enantiomer substrate that liberates methanol and the free amino acid as hydrolysis proceeds; methanol release can be monitored by gas chromatography using a polyethylene glycol capillary column, and released amino acid is quantified by ninhydrin assay or HPLC with fluorescence detection after o-phthaldialdehyde derivatization. In α-chymotrypsin-catalyzed kinetic resolution of racemic tyrosine methyl ester, the enzyme selectively hydrolyzes the L-configured ester, leaving the unreacted D-tyrosine methyl ester fraction enriched and recoverable as the hydrochloride salt after acidification and evaporation. The isolated product is then assessed by the chiral HPLC method described for the D-enantiomer. Published data for this specific configuration are limited when using immobilized Candida antarctica lipase B or other lipase preparations; enzyme loading and buffer ionic strength are therefore treated as process variables during screening rather than fixed from literature values.

The terminal output of this segment is either an enantioenriched ester fraction for chiral building block isolation or activity data used to rank immobilization supports. No additional protecting-group compliance is required for this application beyond general laboratory safety, but when the resolved ester is carried into peptide synthesis, residual enzyme protein is removed by silica gel filtration and solvent wash with 0.1 M hydrochloric acid in ethyl acetate. This ensures the subsequent coupling reaction is not inhibited by residual protein surfaces that adsorb the activated amino acid intermediate.

Multi-Kilogram N-Protection Does Not Tolerate Uncontrolled pH Drift

In a 50 L jacketed glass reactor, N-tert-butoxycarbonyl protection of D-tyrosine methyl ester hydrochloride is performed with 1.1 equivalents of di-tert-butyl dicarbonate in tert-butanol/water 1:1 v/v at 0–5 °C. The pH is initially adjusted to 9.0 with 2 M sodium hydroxide and maintained by a pH-stat pump during the slow addition of the Boc anhydride. Uncontrolled pH drift below 8.0 slows conversion, while drift above 10.5 promotes methyl ester saponification and phenol O-acylation, both of which reduce the selectivity of the N-Boc intermediate. The reaction is stirred for 6–8 h while conversion is monitored by reverse-phase HPLC with UV detection at 210 nm. After complete consumption of the starting hydrochloride, the mixture is extracted with ethyl acetate, washed with 0.5 M potassium bisulfate and brine, dried over magnesium sulfate, and concentrated under reduced pressure at 25–30 °C. The resulting N-Boc-D-tyrosine methyl ester is used as a liquid or low-melting intermediate for subsequent D-tyrosinamide formation or peptide chain extension in pharmaceutical intermediates.

Batch-to-batch variability in the vacuum-dried product is controlled by loss on drying per USP <731>, residual solvent analysis per USP <467>, and elemental impurity screening per ICH Q3D. The solid form is hygroscopic; processing areas with relative humidity above 60% require dry nitrogen purging of the reactor during discharge and product packaging in sealed polyethylene drums with desiccant bags. Temperature control during distillation is critical because the methyl ester undergoes transesterification or decomposition if the internal temperature exceeds 40 °C for extended periods in the presence of residual alcohol. Under these constraints, the final N-protected ester can be shipped as a non-sterile intermediate for sterile filtration during subsequent peptide API production.